Unravelling of diseases is achieved in steps by sequentially describing the
ir phenotype, natural course, aetiology and pathogenesis. Through succinct
clinical observation, conglomerates of heterogeneous connective-tissue diso
rders, such as various forms of disproportionate dwarfism, have been split
into well-defined entities. They have often been confirmed by biochemical a
nd molecular analysis. On the other hand, seemingly disparate disorders hav
e been shown to be pathogenetically related and to be variable expressions
of common defects. Examples are the mucopolysaccharidoses and type II colla
genopathies. Disease recognition through splitting and lumping has improved
prevention and prognostication. It is the basic requirement for future the
rapeutic attempts on a pathogenetic or molecular level.